T he sad incident of the Dana crash of March 2012 and protracted delays that preceded the release of bodies to affected families portrayed Nigeria’s inability to carry out Deoxyribonucleic acid (DNA) biotechnology to the international community. While countries like United States of America, Bri
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp